Fmoc-N-Me-Phe-OH

CAS No. 77128-73-5

Fmoc-N-Me-Phe-OH( Fmoc-N-methyl-L-phenylalanine )

Catalog No. M20604 CAS No. 77128-73-5

Fmoc-N-Me-Phe-OH is a peptide inhibitor of Malaria Parasite.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fmoc-N-Me-Phe-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    Fmoc-N-Me-Phe-OH is a peptide inhibitor of Malaria Parasite.
  • Description
    Fmoc-N-Me-Phe-OH is a peptide inhibitor of Malaria Parasite.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Fmoc-N-methyl-L-phenylalanine
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Malaria Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    77128-73-5
  • Formula Weight
    401.46
  • Molecular Formula
    C25H23NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (249.09 mM)
  • SMILES
    CN(C(Cc1ccccc1)C(O)=O)C(=O)OCC1c2ccccc2-c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Harris K S Casey J L Coley A M et al. Rapid Optimization of a Peptide Inhibitor of Malaria Parasite Invasion by Comprehensive N-Methyl Scanning[J]. Journal of Biological Chemistry 2009 284(14):9361-9371.
molnova catalog
related products
  • GSK3186899

    GSK3186899 is an inhibitor of Cdc2-related kinase 12 with an EC50 of 1.4 μM for L. donovani.

  • pCDPK1/TgCDPK1-IN-3

    CpCDPK1/TgCDPK1-IN-3 is a dual inhibitor of CpCDPK1 and TgCDPK1 with an IC50 of 0.003 μM for CpCDPK1 and 0.0036 μM for TgCDPK1.

  • Eflornithine

    Eflornithine (DFMO) is a selective and orally available ornithine decarboxylase inhibitor that delays hair overgrowth.Eflornithine is used in the study of African trypanosomiasis, malignant glioma, and sleeping sickness.